Medical clinic boards; certain boards authorized to readjust debts under federal bankruptcy laws
SB222 authorizes certain medical clinic boards in Alabama to use federal bankruptcy procedures to readjust their debts when they lease property to a licensed acute care hospital or general health care provider that has voluntarily filed for Chapter 11 bankruptcy. The bill adds Section 11-58-5.2 to the Code of Alabama 1975 and expressly gives the State’s assent for these boards to proceed under federal law governing municipal debt readjustment and bankruptcy-related relief.
The bill also provides immunity protections for members of the board of directors of an eligible medical clinic board. Board members are shielded from personal and official-capacity liability for claims arising from acts, errors, or omissions within the scope of their duties, except for intentional, willful, or wanton misconduct. The bill further states that purchasing insurance does not reduce or waive that immunity, and it takes effect immediately upon enactment.
SB222 changes Alabama law by creating a specific statutory authorization for qualifying medical clinic boards to enter federal bankruptcy proceedings and restructure debt, which may help stabilize financially distressed health-care-related entities tied to leased clinic property. It also expands legal protections for board members by limiting civil liability for actions taken in the course of board service, while preserving liability for intentional or reckless misconduct. The affected parties are medical clinic boards, their directors, and indirectly the hospitals or health care providers that lease the property and are in Chapter 11 bankruptcy.
The bill appears to have been broadly supported and noncontroversial in the legislative process. It passed both chambers with unanimous votes in the recorded roll calls, and there is no committee transcript indicating opposition or extended debate. The voting history suggests consensus that the measure was a targeted, technical fix for debt restructuring and governance protection in a health-care finance context.
No significant contention is reflected in the available record. The only issues that could have prompted discussion are the scope of the bankruptcy authorization and the liability immunity for board members, especially whether those protections are too broad or could limit accountability. However, the unanimous votes and absence of recorded committee debate suggest those concerns were not politically divisive or were resolved without opposition.